AnaptysBio, Inc. (LON:0HFQ)
London flag London · Delayed Price · Currency is GBP · Price in USD
26.36
-0.56 (-2.08%)
At close: Jul 15, 2025

AnaptysBio Revenue

AnaptysBio had revenue of $27.77M USD in the quarter ending March 31, 2025, with 286.84% growth. This brings the company's revenue in the last twelve months to $111.87M, up 387.20% year-over-year. In the year 2024, AnaptysBio had annual revenue of $91.28M with 432.03% growth.

Revenue (ttm)
$111.87M
Revenue Growth
+387.20%
P/S Ratio
6.80
Revenue / Employee
$822.59K
Employees
136
Market Cap
588.77M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 91.28M 74.12M 432.03%
Dec 31, 2023 17.16M 6.87M 66.78%
Dec 31, 2022 10.29M -52.89M -83.72%
Dec 31, 2021 63.18M -11.83M -15.77%
Dec 31, 2020 75.00M 67.00M 837.50%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 42.56B
HSBC Holdings 44.89B
Shell 217.54B
Unilever 50.25B
British American Tobacco p.l.c. 25.87B
Rolls-Royce Holdings 18.91B
Rio Tinto Group 42.86B
RELX PLC 9.43B
Revenue Rankings